Pharmaco - Press Releases

Date	Title	Company
08-Feb-2023	Sequana Medical announces the successful completion of pre-clinical studies with its second-generation DSR product for congestive heart failure	Sequana Medical
08-Feb-2023	InvestEU: EIB Agrees to a €18 Million Loan to Estonian Biotech Icosagen for Innovative R&D Technologies and New cGMP Production Facility	Icosagen AS
08-Feb-2023	InvestEU: EIB Agrees to a €18 Million Loan to Estonian Biotech Icosagen for Innovative R&D Technologies and New cGMP Production Facility	B3C newswire
08-Feb-2023	Spexis and SPRIM Global Investments (SGI) Announce Plans for Clinical Trial Partnership to Fund up to Half of the Projected Phase 3 Clinical Development Costs of ColiFin®	Spexis AG
08-Feb-2023	Relief Therapeutics Provides an Update on its Financing Strategy	Relief Therapeutics Holding SA
08-Feb-2023	CureVac Announces Pricing of Upsized Public Offering of Common Shares	CureVac
07-Feb-2023	iTeos to Present at SVB Securities Global Biopharma Conference	iTeos Therapeutics
07-Feb-2023	AC Immune Awarded New Grants from MJFF and Target ALS Supporting Programs Targeting TDP-43	AC Immune
07-Feb-2023	Pharmaceutical Serialisation – What’s Coming Down the Line?	Domino Printing Sciences
07-Feb-2023	New Country Managing Director and Head of Human Pharma appointed for Boehringer Ingelheim UK & Ireland	Boehringer Ingelheim UK & Ireland
07-Feb-2023	Oxford Science Enterprises strengthens Life Sciences investment team with appointment of Sanne de Jongh as Partner	Oxford Science Enterprises
07-Feb-2023	Moberg Pharmas Year-end report 2022	Moberg Pharma
07-Feb-2023	Evotec SE: Laetitia Rouxel to succeed Enno Spillner as Chief Financial Officer	Evotec SE
07-Feb-2023	Enno Spillner appointed Chief Financial Officer (CFO) of Formycon AG	Formycon AG
06-Feb-2023	CureVac Announces Proposed Public Offering of Common Shares	CureVac
06-Feb-2023	SYNLAB AG: SYNLAB reports trading update for FY 2022 and revises FY 2023 guidance from lower COVID-19 testing	SYNLAB AG
06-Feb-2023	SYNLAB AG: SYNLAB revises FY 2023 guidance from lower COVID-19 testing volumes	SYNLAB AG
06-Feb-2023	iotaSciences Launches New isoPick™ Single-Cell Picker to Further Expand Handling Solutions for Efficient Cell Biology & Gene Therapy Applications	B3C newswire
06-Feb-2023	DEFENCE MANUFACTURING ITS ARM VACCINE IN PREPARATION FOR PHASE I CLINICAL TRIAL AGAINST SOLID TUMORS	Defence Therapeutics Inc.
06-Feb-2023	Aflibercept Biosimilar Candidate FYB203 shows comparable efficacy to the reference product Eylea®1 in Phase III Study	Formycon AG